GKB Ophthalmics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from GKB Ophthalmics Ltd. on BSE

Load latest

GKB Ophthalmics Ltd.

14 Nov 2023

69.88

7.29%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI …

BSE India

The Audit Committee in the meeting held on November 114, 2023, reviewed the utilisation of funds raised through preferential allotment and noted that there was no utilisation of the fund during the quarter ended September 30, 2023.

pdf

GKB Ophthalmics Ltd.

14 Nov 2023

69.88

7.29%

Board Meeting

GKB OPHTHALMICS LTD. - 533212 - Board Meeting Outcome for Meeting Of The Board Of Directors …

BSE India

The meeting of the Board of Directors of the Company was held on November 14, 2023, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company quarter and half year ended September 30, 2023. Pursuant to Regulation 33 (3)(d) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, enclosed please find the following : 1. Standalone Financial Results for the quarter and half year ended September 30, 2023, together with the Limited Review Report. 2. Consolidated Financial Results for the quarter and half year ended September 30, 2023, along with Limited Review Report. The above Unaudited Financial Results and the Limited Review Reports are available on the Company''s website www.gkb.net and on the BSE website www.bseindia.com The Board of Directors'' Meeting started at 04.00 P.M. and ended at 06.45 P.M., on the same day.

pdf

GKB Ophthalmics Ltd.

30 Oct 2023

69.88

7.29%

Board Meeting

GKB OPHTHALMICS LTD. - 533212 - Board Meeting Intimation for Considering And Taking On Record The …

BSE India

GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve Notice is hereby given that a meeting of the Board of Directors of the company will be held on Tuesday, November 14, 2023, inter alia, for considering and taking on record the Unaudited standalone and consolidated Financials Results of the Company for the quarter and half ended September 30, 2023. The Notice can be accessed at the Company''s website at www.gkb.net. Kindly take the information on record.

pdf

GKB Ophthalmics Ltd.

11 Oct 2023, 12:37PM

69.88

7.29%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Submission Of Minutes Of 41St Annual General Meeting Of The …

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to enclose herewith a copy of the Minutes of the proceedings of the 41st Annual General Meeting of the Company, held on 14th September, 2023. Kindly acknowledge receipt of the same.

pdf

GKB Ophthalmics Ltd.

09 Oct 2023

69.88

7.29%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find herewith Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2023. Kindly acknowledge receipt of the same.

pdf

GKB Ophthalmics Ltd.

30 Sep 2023

69.88

7.29%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) …

BSE India

Pursuant to provisions of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015), initimation be and is hereby given that KrishnaGopal Gupta & Sons (HUF), has purchased 7377 equity shares agregregating to Rs. 681872.54 from 14-08-2023 to 28-09-2023, on market, which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulations, 2015. However, as a good corporate governance measure, the disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulations, 2015, is enclosed herewith along with the copy of disclosure received from KrishnaGopal Gupta & Sons(HUF). Please acknowledge and take the same on record.

pdf

GKB Ophthalmics Ltd.

30 Sep 2023

69.88

7.29%

SAST

GKB OPHTHALMICS LTD. - 533212 - Closure of Trading Window

BSE India

Pursuant to SEBI (Prohibition of Insider Trading ) Regulations 2015, as amended from time to time, the "Trading Window" for dealing/trading in the shares of the Company shall remain closed from October 01, 2023, till the completion of 48 hours after the declaration of the financial results of the Company, for quarter ended September 30, 2023. Accordingly, all the Promoters, Directors and Designated Persons of the Company their immediate relatives are being intimated to not to enter into any transaction involving trading in shares of the Company, during the period of closure of Trading Window. Kindly take the information on record.

pdf

GKB Ophthalmics Ltd.

15 Sep 2023

69.88

7.29%

AGM

GKB OPHTHALMICS LTD. - 533212 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Pursuant to Regulation 44 of SEBI(LODR) 2015 please find attached: 1. Consolidated voting results pursuant to regulation 44(3) of SEBI (LODR) 2. Scrutinizers Report Pursuant to Section 108 of the Companies Act, 2013 All the resolutions were passed with requisite majority. Kindly Take the same on record

pdf

GKB Ophthalmics Ltd.

14 Sep 2023

69.88

7.29%

AGM

GKB OPHTHALMICS LTD. - 533212 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

The AGM of the shareholders of the Company was held on September 14, 2023 at the registered office of the Company through VC/OAVM. All the Directors attended the meeting. The Meeting was attended by CFO, Statutory Auditors, Secretarial Auditor and the Scrutinizer. The detailed meeting proceedings is attached.

pdf

GKB Ophthalmics Ltd.

24 Aug 2023

69.88

7.29%

Company Update

GKB OPHTHALMICS LTD. - 533212 - Intimation Of Approval Received For Re-Classification Of Shareholders Of GKB …

BSE India

With reference to the application made by the Company on October 26, 2021, regarding the re-classification of certain shareholders from the "Promoter and Promoter Group'' category to the ''Public'' category and the letter dated October 26, 2021, intimating you of the same, we wish to inform you that the Company has received approval from BSE Limited for re-classification of certain persons namely, Mr. Krishna Murari Gupta, Mrs. Usha Gupta, Mr. Aditya Gupta and Mr. Vivek Gupta from the ''Promoter and Promoter Group'' category of shareholders to ''Public'' category, in accordance with Regulation 31A of the Listing Regulations. The approval of Stock Exchange is enclosed herewith. Kindly take the same on your records.

pdf

Is GKB Ophthalmics Ltd. worth buying?

12 Votes:

Buy 66.67%

Sell 33.33%